Abionyx Pharma SA
PAR:ABNX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abionyx Pharma SA
PAR:ABNX
|
FR |
|
C
|
Construcciones Y Auxiliar De Ferrocarriles SA
MAD:CAF
|
ES |
|
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
|
IT |
|
V
|
Voksel Electric Tbk PT
IDX:VOKS
|
ID |
|
K
|
Kien Hung JSC VN
VN:KHS
|
VN |
|
Maxi-Cash Financial Services Corporation Ltd
SGX:5UF
|
SG |
|
Dynex Capital Inc
NYSE:DX
|
US |
|
V
|
Vienna Insurance Group Wiener Versicherung Gruppe AG
VSE:VIG
|
AT |
|
L
|
Lionheart Holdings
NASDAQ:CUB
|
US |
Wall Street
Price Targets
ABNX Price Targets Summary
Abionyx Pharma SA
According to Wall Street analysts, the average 1-year price target for
ABNX
is 10.71 EUR
with a low forecast of 10.1 EUR and a high forecast of 11.55 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ABNX's stock price target?
Price Target
10.71
EUR
According to Wall Street analysts, the average 1-year price target for
ABNX
is 10.71 EUR
with a low forecast of 10.1 EUR and a high forecast of 11.55 EUR.
What is Abionyx Pharma SA's Revenue forecast?
Projected CAGR
71%
The
compound annual growth rate
of Abionyx Pharma SA's revenue for the next 4 years is
71%.
